- Home
- ULY vs AEON Comparison
ULY vs AEON Comparison
Compare ULY & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULY
- AEON
- Stock Information
- Founded
- ULY 2013
- AEON N/A
- Country
- ULY United States
- AEON United States
- Employees
- ULY N/A
- AEON N/A
- Industry
- ULY
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- ULY
- AEON Health Care
- Exchange
- ULY Nasdaq
- AEON Nasdaq
- Market Cap
- ULY 7.1M
- AEON 8.0M
- IPO Year
- ULY N/A
- AEON N/A
- Fundamental
- Price
- ULY $5.13
- AEON $0.77
- Analyst Decision
- ULY Strong Buy
- AEON Strong Buy
- Analyst Count
- ULY 2
- AEON 1
- Target Price
- ULY $11.50
- AEON $360.00
- AVG Volume (30 Days)
- ULY 28.4K
- AEON 105.1K
- Earning Date
- ULY 08-12-2025
- AEON 08-12-2025
- Dividend Yield
- ULY N/A
- AEON N/A
- EPS Growth
- ULY N/A
- AEON N/A
- EPS
- ULY N/A
- AEON N/A
- Revenue
- ULY $131,235,000.00
- AEON N/A
- Revenue This Year
- ULY N/A
- AEON N/A
- Revenue Next Year
- ULY $21.54
- AEON N/A
- P/E Ratio
- ULY N/A
- AEON N/A
- Revenue Growth
- ULY N/A
- AEON N/A
- 52 Week Low
- ULY $2.99
- AEON $0.38
- 52 Week High
- ULY $17.99
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- ULY 43.88
- AEON 52.05
- Support Level
- ULY $4.77
- AEON $0.63
- Resistance Level
- ULY $5.74
- AEON $0.80
- Average True Range (ATR)
- ULY 0.50
- AEON 0.06
- MACD
- ULY 0.03
- AEON 0.00
- Stochastic Oscillator
- ULY 59.06
- AEON 77.30
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.